These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 18223206

  • 1. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.
    Friday BB, Adjei AA.
    Clin Cancer Res; 2008 Jan 15; 14(2):342-6. PubMed ID: 18223206
    [Abstract] [Full Text] [Related]

  • 2. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ, Der CJ.
    Oncogene; 2007 May 14; 26(22):3291-310. PubMed ID: 17496923
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.
    J Pharmacol Exp Ther; 2009 Jun 14; 329(3):1063-70. PubMed ID: 19258520
    [Abstract] [Full Text] [Related]

  • 5. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R, Piperdi S, Gorlick R.
    Clin Cancer Res; 2008 Oct 15; 14(20):6396-404. PubMed ID: 18927278
    [Abstract] [Full Text] [Related]

  • 6. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P, Arienti C, Amadori D, Fabbri F, Carloni S, Tesei A, Vannini I, Silvestrini R, Zoli W.
    J Cell Physiol; 2009 Jul 15; 220(1):214-21. PubMed ID: 19288493
    [Abstract] [Full Text] [Related]

  • 7. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA, Wilhelm S, Carter C, Kelley SL.
    Semin Oncol; 2006 Aug 15; 33(4):392-406. PubMed ID: 16890795
    [Abstract] [Full Text] [Related]

  • 8. Targeting the RAF-MEK-ERK pathway in cancer therapy.
    Montagut C, Settleman J.
    Cancer Lett; 2009 Oct 08; 283(2):125-34. PubMed ID: 19217204
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Coordinating ERK/MAPK signalling through scaffolds and inhibitors.
    Kolch W.
    Nat Rev Mol Cell Biol; 2005 Nov 08; 6(11):827-37. PubMed ID: 16227978
    [Abstract] [Full Text] [Related]

  • 13. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J, Zhao Y, Kauss MA, Spindel S, Lian H.
    Eur J Cell Biol; 2009 Feb 08; 88(2):103-15. PubMed ID: 19058874
    [Abstract] [Full Text] [Related]

  • 14. Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
    Wang AX, Qi XY.
    IUBMB Life; 2013 Sep 08; 65(9):748-58. PubMed ID: 23893853
    [Abstract] [Full Text] [Related]

  • 15. Targeting the ERK signaling pathway in cancer therapy.
    Kohno M, Pouyssegur J.
    Ann Med; 2006 Sep 08; 38(3):200-11. PubMed ID: 16720434
    [Abstract] [Full Text] [Related]

  • 16. Raf pathway inhibitors in oncology.
    Bollag G, Freeman S, Lyons JF, Post LE.
    Curr Opin Investig Drugs; 2003 Dec 08; 4(12):1436-41. PubMed ID: 14763129
    [Abstract] [Full Text] [Related]

  • 17. B-Raf kinase inhibitors for cancer treatment.
    Li N, Batt D, Warmuth M.
    Curr Opin Investig Drugs; 2007 Jun 08; 8(6):452-6. PubMed ID: 17621874
    [Abstract] [Full Text] [Related]

  • 18. Novel mitogen-activated protein kinase kinase inhibitors.
    Chapman MS, Miner JN.
    Expert Opin Investig Drugs; 2011 Feb 08; 20(2):209-20. PubMed ID: 21235429
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels.
    Dumaz N, Marais R.
    FEBS J; 2005 Jul 08; 272(14):3491-504. PubMed ID: 16008550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.